AI assistant
DEXCOM INC — Director's Dealing 2020
May 29, 2020
30198_dirs_2020-05-28_bf2405a7-734f-443f-8f4d-75331ca889b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-05-26
Reporting Person: Selvaraj Shelly Ramasamy (SVP Information Technology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-26 | Common Stock | S | 1474 | $408.49 | Disposed | 23241 | Direct |
Footnotes
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Included in this number are 16,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021.